1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRegional and Local Dementia Grants (Minnesota) is sponsored by Minnesota Board on Aging (MBA). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Dementia Grants RFP / Minnesota Board on Aging (MBA) Help shape the future of aging in Minnesota. Take the state's Comprehensive Aging Survey and share your opinions, thoughts and ideas! Visit the survey website to learn more about this effort.
Regional and Local Dementia Grants The Minnesota Board on Aging administers a competitive grant program focusing on Alzheimer's disease and other dementias and their impact on family, friends and caregivers.
Grants should: Increase awareness of Alzheimer's disease and other dementias Increase the rate of cognitive testing Promote the benefits of early identification Connect family, friends and neighbors who are caregiving with education, support and resources.
Grants should stimulate collaboration and coordination and strengthen community relationships and partnerships that promote the benefit of physician consultation for all people who may have a memory or cognitive concern.
Grant term: Up to 24 months (July 1, 2026 — June 30, 2028) Maximum request: $150,000 Total funds available: $750,000 Match requirement: 25 percent match is required for requests above $50,000 Grant application and portal SFY 2027 Regional and Local Dementia Grants RFP (PDF) To apply, go to the grant portal . Dec. 1, 2025: Request for Proposal (RFP) posted Jan.
7, 2026: Dementia Grant Responders Conference, 1-3:30 p. m. Central Time Responders conference presentation slides (PDF) RFP questions and answers (Q & A) (PDF) (Updated every two weeks) March 20, 2026: Applications due by 4 p.
m. Central Time April 1, 2026: Phase I denial notices sent to responders April and May, 2026: Review and scoring applications June 2026: Negotiate contracts July 1, 2026: SFY 2027 grantee anticipated start date Grant Contact: Jane Cunningham — jane. e.
cunningham@state. mn.
us SFY27 MBA Budget Workbook (XML) Dementia Knowledge Capture Form (XML) Dementia Knowledge Capture Form Instructions (PDF) Number of applications submitted (as of March 20, 2026): 49 MBA Disclosure of Funding Form 7018 (PDF) MBA Exceptions to Terms and Conditions Form 7019 (PDF) MBA Responder Declarations Form 7020 (PDF) MBA Documentation to Establish Financial Responsibility 7896 (PDF) State Fiscal Year 2026 (PDF) State Fiscal Year 2025 (PDF) State Fiscal Year 2024 (PDF)
According to the current listing, eligibility includes: Qualified responders for regional and local projects. Statewide proposals are not eligible. Organizations previously awarded a regional and local dementia grant are eligible to reapply. Confirm the full requirements in the official notice before applying.
Regional and Local Dementia Grants (Minnesota) is funded by Minnesota Board on Aging (MBA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article